Intelligent Ultrasound Group plc

("Intelligent Ultrasound" or the "Group" or the "Company")

Result of General Meeting

Shareholders approve capital reduction

Intelligent Ultrasound Group plc (AIM: IUG), the ultrasound simulation and education company, announces that at the general meeting held on 15^th October 2024, shareholders approved the capital reduction, the preliminary step to provide the distributable reserves required to return capital to shareholders following the sale of the Clinical AI Business to GE HealthCare for £40.5 million.

Results show that 99.99% of the shares voted (representing approximately 60% of the total shares outstanding) were in favour, with 0.01% against.

The capital reduction is expected to be confirmed by Court Order on 18^th November, after which further details on the Company's plans for its Simulation Business will be announced.

For further information, please contact:

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: IUG) is one of the world's leading ultrasound simulation and education companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market. The company's main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator, the new BabyWorks Neonate and Paediatric training simulator and NeedleTrainer, which teaches real-time ultrasound-guided needling. To date over 1,800 simulators have been sold to over 800 medical institutions around the world.

www.intelligentultrasound.com